<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(4)</volume><submitter>Lachassinne E</submitter><funding>Assistance Publique - Hôpitaux de Paris</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The extent to which very young children contribute to the transmission of SARS-CoV-2 is unclear. We aimed to estimate the seroprevalence of antibodies against SARS-CoV-2 in daycare centres that remained open for key workers' children during a nationwide lockdown in France.&lt;h4>Methods&lt;/h4>Children and staff who attended one of 22 daycare centres during a nationwide lockdown in France (between March 15 and May 9, 2020) were included in this cross-sectional, multicentre, seroprevalence study. Hospital staff not occupationally exposed to patients with COVID-19, or to children, were enrolled in a comparator group. The primary outcome was SARS-CoV-2 seroprevalence in children, daycare centre staff, and the comparator group. The presence of antibodies against SARS-CoV-2 in capi</pubmed_abstract><journal>The Lancet. Child &amp; adolescent health</journal><pagination>256-264</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9180428</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.</pubmed_title><pmcid>PMC9180428</pmcid><pubmed_authors>Caseris M</pubmed_authors><pubmed_authors>Wannepain E</pubmed_authors><pubmed_authors>Lorrot M</pubmed_authors><pubmed_authors>Pinquier D</pubmed_authors><pubmed_authors>Lescano O</pubmed_authors><pubmed_authors>Gajdos V</pubmed_authors><pubmed_authors>Brichler S</pubmed_authors><pubmed_authors>Basmaci R</pubmed_authors><pubmed_authors>Hentgen V</pubmed_authors><pubmed_authors>Masson R</pubmed_authors><pubmed_authors>Zahar JR</pubmed_authors><pubmed_authors>Charbonnier L</pubmed_authors><pubmed_authors>Mestre N</pubmed_authors><pubmed_authors>Rabehi B</pubmed_authors><pubmed_authors>Cohen R</pubmed_authors><pubmed_authors>Lachassinne E</pubmed_authors><pubmed_authors>Guilluy C</pubmed_authors><pubmed_authors>Naud A</pubmed_authors><pubmed_authors>Bloch-Queyrat C</pubmed_authors><pubmed_authors>Romain AS</pubmed_authors><pubmed_authors>Dommergues MA</pubmed_authors><pubmed_authors>Jung C</pubmed_authors><pubmed_authors>Vuillaume X</pubmed_authors><pubmed_authors>Hausherr E</pubmed_authors><pubmed_authors>Boelle PY</pubmed_authors><pubmed_authors>Pinto Cardoso G</pubmed_authors><pubmed_authors>de Pontual L</pubmed_authors><pubmed_authors>COVIDOCRECHE collaborators</pubmed_authors><pubmed_authors>Aupiais C</pubmed_authors><pubmed_authors>Chosidow A</pubmed_authors><pubmed_authors>Vie le Sage F</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.</name><description>&lt;h4>Background&lt;/h4>The extent to which very young children contribute to the transmission of SARS-CoV-2 is unclear. We aimed to estimate the seroprevalence of antibodies against SARS-CoV-2 in daycare centres that remained open for key workers' children during a nationwide lockdown in France.&lt;h4>Methods&lt;/h4>Children and staff who attended one of 22 daycare centres during a nationwide lockdown in France (between March 15 and May 9, 2020) were included in this cross-sectional, multicentre, seroprevalence study. Hospital staff not occupationally exposed to patients with COVID-19, or to children, were enrolled in a comparator group. The primary outcome was SARS-CoV-2 seroprevalence in children, daycare centre staff, and the comparator group. The presence of antibodies against SARS-CoV-2 in capi</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-05-09T18:57:13.554Z</modification><creation>2025-04-05T19:57:52.788Z</creation></dates><accession>S-EPMC9180428</accession><cross_references><pubmed>33571450</pubmed><doi>10.1016/S2352-4642(21)00024-9</doi></cross_references></HashMap>